Johnson & Johnson (JNJ)
Johnson & Johnson reported revenue of $94.19B for the fiscal year ended Dec 28, 2025, up 6.0% from $88.82B the year before. Net income was $26.80B, a net margin of 28.5% (prior year: $14.07B). At the end of that fiscal year the company reported total assets of $199.21B and shareholders' equity of $81.54B.
Revenue
$94.19B
+6.0% vs prior year
Net income
$26.80B
Net margin 28.5%
Diluted EPS
$11.03
USD per share
Total assets
$199.21B
At Dec 28, 2025
Equity
$81.54B
At Dec 28, 2025
Shares outstanding
2,407M
As of Oct 15, 2026
Explore Johnson & Johnson's filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Oct 21, 2026
- 10-QFiled Jul 23, 2026
- 10-QFiled Apr 22, 2026
- 10-KFiled Feb 11, 2026
- 10-QFiled Oct 22, 2025
- 10-QFiled Jul 24, 2025
Compare Johnson & Johnson
- PFEJNJ vs PFE
Source: SEC EDGAR XBRL company facts for CIK 200406 (raw data). Most recent filing in this dataset: 10-Q filed Oct 21, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.